Table 1.
Patient characteristics who underwent the OTO IVM
| No of patients | 10 |
|---|---|
| Age (years) | |
| Range | 16–36 |
| Mean ± SE | 29.40 ± 1.76 |
| BMI (kg/m2) | |
| Range | 18–44 |
| Mean ± SE | 26.80 ± 2.45 |
| Diagnosis, n (%) | |
| Ovarian cancer | 4 (40%) |
| Cervical cancer | 3 (30%) |
| Endometrial cancer | 2 (20%) |
| Borderline ovarian tumor | 1 (10%) |
| Menarche | |
| Range | 11–14 |
| Mean ± SE | 12.70 ± 0.36 |
| Menstrual cycle | |
| Range | 27–37 |
| Mean ± SE | 31.67 ± 1.59 |
| Bleeding duration | |
| Range | 4–8 |
| Mean ± SE | 5.50 ± 0.37 |
| Pregnancies in the past | 2 (20%) |
| Ovariectomy in the past | 2 (20%) |
| Hysterectomy | 6 (60%) |
| AMH serum level, (ng/mL) | |
| Range | 0.70–19.8 |
| Mean ± SE | 5.14 ± 1.91 |
BMI body mass index, AMH anti Müllerian hormone, OTO IVM ovarian tissue oocyte in vitro maturation, SE standard error